Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells

Acta Virologica

Volumn 45, Issue 4, 2001, Pages 243-247

  Nemeckova S ^a   Hainz, P ^a   Otahal P ^a   Gabriel, P ^a   Sroller V ^a   Kutinova L ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Dendritic cells; Early promoter; Gene expression; MVA; Poxviruses; Vaccinia virus

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; DIPLOIDY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; NONHUMAN; POXVIRUS; PROMOTER REGION; SAFETY; STRAIN DIFFERENCE; VACCINIA VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, NORTHERN; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICE; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; VACCINIA VIRUS;

ANIMALIA; GALLUS GALLUS; MAMMALIA; POXVIRIDAE; VACCINIA VIRUS;

EID: 0035705657     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses
2. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes
3. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line
4. Solubilization in formamide protects RNA from degradation
5. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins
6. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells
7. The purification of four strains of poxvirus
8. A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Restricted expression of HBV antigens in human diploid cells
9. Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them
10. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
11. Vaccination against pox diseases under immunosuppressive conditions
12. Der pockenimpfstamm MVA: Marker, genetische struktur, erfahrungen mit der parenteralen schutzimpfung und verhalten im abwehrgeschwachten organismus
13. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
14. Expression of a preproinsulin-beta-galactosidase gene fusion in mammalian cells
15. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: Virus fate and activation of B- and T-cell immune responses in comparison with the Western reserve strain and advantages as a vaccine
16. Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants
17. Nonreplicating vaccinia vector efficiently expresses recombinant genes
18. Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus